Core Laboratories Inc

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Core Labs reports strong Q4 performance, eyes growth opportunities

Core Laboratories Inc delivered a solid performance in Q4 2022, focusing on financial strength, operational efficiency, and future growth prospects. Despite facing challenges from external factors, the company remains optimistic about opportunities in the energy sector and its ability to create value for shareholders.

Core Laboratories Inc reports robust Q1 earnings, eyes EOR opportunities

Core Laboratories Inc delivered strong financial results, highlighted operational efficiencies, and outlined growth strategies amidst industry challenges. The company's focus on innovation, debt reduction, and cost savings bodes well for future performance and shareholder value.

Core Labs reports solid Q2 performance, eyes international growth

Core Laboratories Inc showcased strong financial performance in Q2 2023, with a focus on operational efficiency and technological advancement.
The company's commitment to maximizing free cash flow, returns on invested capital, and shareholder value underscores its financial discipline and strategic priorities.
Despite challenges in the US land sector, Core Labs remains optimistic about international growth opportunities and technological advancements driving future success.

Core Laboratories Inc reports strong Q3 performance amidst market challenges

Core Laboratories Inc delivered a strong Q3 performance with improvements in key financial metrics. While facing challenges in certain segments, the company's strategic focus on innovation and efficiency positions it well for future opportunities. Core Labs remains optimistic about its outlook and is committed to driving growth and value for shareholders.

Core Laboratories reports steady Q4 performance amidst operational challenges

Core Laboratories navigated challenges in Q4 with a focus on debt reduction, innovation, and operational excellence, showcasing resilience and adaptability.
While facing headwinds in certain segments, Core Labs remains committed to long-term sustainability, shareholder value, and technological advancement.
Strategic initiatives and operational highlights underscore Core's leadership in the industry, setting the stage for future growth and market expansion.

Core Labs maintains steady performance amidst geopolitical challenges and debt reduction

Core Laboratories Inc delivered a resilient performance in Q1 2024, focusing on operational efficiency and debt reduction amidst external challenges.
The company's strategic strengths lie in international growth prospects, technology investments, and commitment to financial stability.
Challenges from geopolitical conflicts and operational disruptions highlight the need for adaptability and diversification in Core Labs' business approach.
Opportunities abound in capitalizing on international growth, technology advancements, and maximizing return on invested capital for sustainable growth.

Core Laboratories reports revenue growth and debt reduction in Q3

Core Laboratories Inc delivered a solid financial performance in Q3 2024, with revenue growth, improved margins, and reduced debt levels.
While facing challenges in a competitive market and capital expenditure constraints, the company remains focused on sustaining profitability and operational efficiency.
Opportunities lie in leveraging segment revenue growth, debt reduction strategies, and exploring new avenues for expansion and partnerships.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. The company was founded on May 1, 2023 and is headquartered in Houston, TX.

Core Laboratories' (CLB) stock down 3% since the company's first-quarter earnings and revenues beat estimates.

Core Labs (CLB) Stock Down 3% Since Q1 Earnings & Sales Beat

The reservoir optimization company continues to have strong medium-term growth prospects.

Why Shares in Core Labs Fell This Week

Core Laboratories N.V. (NYSE:CLB ) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Larry Bruno - Chairman and CEO Chris Hill - CFO Gwen Gresham - Head of IR Conference Call Participants Stephen Gengaro - Stifel Taylor Zurcher - Tudor, Pickering, & Holt Operator Good morning, and welcome to the Core Lab Q1 2022 Earnings Call.

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q1 2022 Results - Earnings Call Transcript

The oilfield service company is falling despite posting solid first-quarter results.

Why Core Laboratories Stock Is Slumping Today

Core Laboratories (CLB) delivered earnings and revenue surprises of 33.33% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Tops Q1 Earnings and Revenue Estimates

FIRST QUARTER REVENUE OF $115.3 MILLION; UP 6% YEAR-OVER-YEAR FIRST QUARTER GAAP EPS OF $(0.04); EPS, EX-ITEMS, $0.08 LAUNCH OF INDUSTRY CARBON CAPTURE AND SEQUESTRATION ("CCS") CONSORTIUM CCS STRATEGIC ALLIANCE WITH TALOS ENERGY INC. REDUCES NET DEBT BY $3.3 MILLION ANNOUNCES Q2 2022 QUARTERLY DIVIDEND AMSTERDAM , April 27, 2022 /PRNewswire/ -- Core Laboratories N.V.

CORE LAB REPORTS FIRST QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS

Core Laboratories (CLB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Is a Surprise Coming for Core Laboratories (CLB) This Earnings Season?

National Energy Services Reunited

Schlumberger

Oil plunged on fresh Chinese lockdown worries.

Why Schlumberger, Core Laboratories, and National Energy Services Reunited Plunged Today

HUNTSVILLE, Ala.--(BUSINESS WIRE)-- #diagnostics--Madison Core Laboratories (“MCL”) is pleased to announce the expansion of its clinical laboratory in Huntsville, Alabama. “This expansion increases our laboratory space by approximately 50 percent and will allow MCL to enhance its comprehensive diagnostic testing product lines and launch additional innovative services to better the lives of the patients we serve,” commented Carlo Crespo, MD, Chief Executive Officer. Phase 1 of the Huntsville Lab expansion will

Madison Core Laboratories Announces Huntsville Laboratory Expansion

Core Laboratories is benefiting from strong conditions in the energy sector. The company sees current oil and gas prices supporting higher sector investments into new development projects as a growth tailwind.

Core Laboratories: Bullish Into Multi-Year Oil And Gas Investment Cycle

HUNTSVILLE, Ala.--(BUSINESS WIRE)--Madison Core Laboratories, LLC (MCL) announces the appointment of Jeff Wisotzkey, Ph.D., HCLD, CC, as Chief Scientific Officer and Laboratory Director. Dr. Wisotzkey brings to MCL over 25 years of experience in scientific leadership and laboratory operations in multiple areas including Molecular Diagnostics, Chemistry/Immunochemistry, Immunology, Microbiology, and Toxicology. In his new role, which is in line with the Company's strategic planning efforts, Dr.

Madison Core Laboratories Appoints New Chief Scientific Officer

Talos Energy Inc

AMSTERDAM , March 17, 2022 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") and Talos Energy Inc. ("Talos") (NYSE: "TALO") have announced a strategic alliance to provide technical evaluation and assurance for carbon capture and sequestration ("CCS") opportunities.

Core Laboratories, Euronext Amsterdam and Talos Energy Inc. have announced a strategic alliance to provide technical evaluation and assurance for carbon capture and sequestration opportunities.

In addition to the geopolitical risks, Core Laboratories (CLB) suffered operational hiccups after a much larger-than-usual number of its employees tested positive for COVID during the first quarter.

Core Labs (CLB) Hit by Russia Conflict, Pegs Down Q1 View

CONSTRUCTIVE VIEW ON 2022 COMPANY OUTLOOK LAUNCH OF INDUSTRY CARBON CAPTURE AND SEQUESTRATION CONSORTIUM FIRST QUARTER 2022 EARNINGS WEBCAST AT 7:30 A.M. CDT / 2:30 P.M.

CORE LAB ANNOUNCES REVISED Q1 2022 GUIDANCE

Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Core Laboratories (CLB) Moves 14.2% Higher: Will This Strength Last?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Why Is Core Laboratories (CLB) Up 7.1% Since Last Earnings Report?

Core Laboratories' (CLB) fourth-quarter earnings are on par with the consensus mark, while revenues beat estimates as a result of a strong performance in the Production Enhancement segment.

Core Labs (CLB) Q4 Earnings Meet Estimates, Revenues Surpass

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2021 Results - Earnings Call Transcript

Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 1.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Meets Q4 Earnings Estimates

AMSTERDAM, Feb. 2, 2022 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported fourth quarter 2021 revenue of $125,100,000.

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS FROM CONTINUING OPERATIONS:

Occidental Petroleum

Exxon Mobil

It was a great week for oil stocks amid a busy week of news and a market rotation.

Why ExxonMobil, Occidental Petroleum, and Core Laboratories Surged Double Digits This Week

AMSTERDAM, Jan. 4, 2022 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2021 conference call over the Internet at 7:30 a.m. CST / 2:30 p.m.

CORE LABORATORIES' FOURTH QUARTER 2021 WEBCAST AT 7:30 A.M. CST / 2:30 P.M.

Centennial Resource Development

ConocoPhillips

OPEC+ isn't scared of omicron. Should you be?

Why ConocoPhillips, Core Labs, and Centennial Resource Stocks Just Popped

In the September quarter, Core Labs (CLB) generates $11.9 million as operating cash and its capex totals $3.1 million, leading to an $8.8-million free cash flow (FCF) recognition.

Core Labs' (CLB) Stock Up 9.4% Despite Missing on Q3 Earnings

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q3 2021 Results - Earnings Call Transcript

News for Core Laboratories Inc Stock (CLB)